Rtw Investments
Latest statistics and disclosures from Rtw Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RCKT, IMVT, PTCT, MRTX, STOK, and represent 33.47% of Rtw Investments's stock portfolio.
- Added to shares of these 10 stocks: ARVN (+$152M), GMED (+$107M), Tarsus Pharmaceuticals (+$99M), Pulmonx Corp (+$75M), ILMN (+$69M), C4 Therapeutics (+$69M), KURA (+$56M), FPRX (+$43M), CRIS (+$31M), IDYA (+$26M).
- Started 26 new stock positions in Biodesix, FPRX, Bioatla, Vincera Pharma, ARVN, Tarsus Pharmaceuticals, KURA, Lifesci Acquisition Ii Corp, CRIS, Cerevel Therapeutics Hldng I.
- Reduced shares in these 10 stocks: Myokardia (-$128M), BAX (-$87M), , FIXX (-$27M), VXRT (-$23M), ADAP (-$21M), OSUR (-$20M), ALT (-$18M), AMRS (-$15M), TBIO (-$14M).
- Sold out of its positions in ADAP, ALT, AMRS, ARCT, BAX, EQ, FIXX, INCY, Lifesci Acquisition Corp unit 03/31/2025, Myokardia. TMDX, VXRT, Arya Sciences Acquisition, QURE.
- Rtw Investments was a net buyer of stock by $508M.
- Rtw Investments has $6.0B in assets under management (AUM), dropping by 43.50%.
Tip: Access up to 7 years of quarterly data
Positions held by RTW INVESTMENTS consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Rtw Investments
Companies in the Rtw Investments portfolio as of the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 15.7 | $936M | 17M | 54.84 | ||
| Immunovant (IMVT) | 5.9 | $351M | 7.6M | 46.19 | ||
| Ptc Therapeutics I (PTCT) | 4.3 | $258M | +5% | 4.2M | 61.03 | |
| Mirati Therapeutics (MRTX) | 3.9 | $232M | -3% | 1.1M | 219.64 | |
| Stoke Therapeutics (STOK) | 3.7 | $220M | 3.5M | 61.93 | ||
| Alnylam Pharmaceuticals (ALNY) | 3.7 | $219M | 1.7M | 129.97 | ||
| Natera (NTRA) | 2.9 | $170M | 1.7M | 99.52 | ||
| Dicerna Pharmaceuticals (DRNA) | 2.7 | $160M | 7.3M | 22.03 | ||
| Arvinas Ord (ARVN) | 2.6 | $152M | NEW | 1.8M | 84.93 | |
| Vericel (VCEL) | 2.3 | $140M | +17% | 4.5M | 30.88 | |
| Axsome Therapeutics (AXSM) | 2.3 | $136M | 1.7M | 81.47 | ||
| Illumina (ILMN) | 2.2 | $134M | +106% | 362k | 370.00 | |
| Cerner Corporation (CERN) | 2.2 | $134M | +22% | 1.7M | 78.48 | |
| Masimo Corporation (MASI) | 2.1 | $126M | +4% | 469k | 268.38 | |
Setup an alertRtw Investments will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Globus Med Cl A (GMED) | 1.8 | $107M | NEW | 1.6M | 65.22 | |
| Avidity Biosciences Ord (RNA) | 1.7 | $102M | 4.0M | 25.52 | ||
| Tarsus Pharmaceuticals | 1.7 | $99M | NEW | 2.5M | 40.18 | |
| Axonics Modulation Technolog (AXNX) | 1.6 | $94M | 1.9M | 49.92 | ||
| Dermtech Ord ord (DMTK) | 1.6 | $94M | 2.9M | 32.44 | ||
| 10x Genomics Cl A Com (TXG) | 1.6 | $94M | 661k | 141.60 | ||
| Athira Pharma (ATHA) | 1.5 | $89M | 2.7M | 33.10 | ||
| Establishment Labs Holdings Ord (ESTA) | 1.5 | $87M | 2.3M | 37.64 | ||
| Frequency Therapeutics (FREQ) | 1.5 | $87M | 2.5M | 35.26 | ||
| Adverum Biotechnologies (ADVM) | 1.3 | $78M | 7.2M | 10.84 | ||
| Guardant Health (GH) | 1.3 | $75M | +23% | 582k | 128.88 | |
| Pulmonx Corp | 1.3 | $75M | NEW | 1.1M | 66.25 | |
| Protagonist Therapeutics (PTGX) | 1.2 | $74M | +7% | 3.7M | 20.16 | |
| C4 Therapeutics Com Stk | 1.2 | $69M | NEW | 2.1M | 31.96 | |
| Tandem Diabetes Care Com New (TNDM) | 1.1 | $63M | +9% | 661k | 95.68 | |
| Celldex Therapeutics Com New (CLDX) | 1.0 | $60M | +9% | 3.4M | 17.52 | |
| Kura Oncology (KURA) | 0.9 | $56M | NEW | 1.7M | 32.66 | |
| Translate Bio (TBIO) | 0.9 | $55M | -20% | 3.0M | 18.43 | |
| Nanostring Technologies (NSTG) | 0.9 | $54M | -15% | 804k | 66.88 | |
| Castle Biosciences (CSTL) | 0.9 | $54M | +7% | 799k | 67.15 | |
| Relmada Therapeutics (RLMD) | 0.8 | $49M | 1.5M | 32.07 | ||
| Iveric Bio (ISEE) | 0.8 | $47M | 6.7M | 6.91 | ||
| Five Prime Therapeutics (FPRX) | 0.7 | $43M | NEW | 2.5M | 17.01 | |
| Cytokinetics Com New (CYTK) | 0.7 | $41M | 2.0M | 20.66 | ||
| Agenus Com New (AGEN) | 0.7 | $41M | 13M | 3.18 | ||
| Oyster Point Pharma (OYST) | 0.6 | $36M | 1.9M | 18.82 | ||
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.6 | $36M | 5.4M | 6.68 | ||
| Iteos Therapeutics (ITOS) | 0.6 | $36M | +18% | 1.1M | 33.49 | |
| Outset Med (OM) | 0.6 | $33M | +44% | 585k | 56.84 | |
| Trillium Therapeutics Com New (TRIL) | 0.5 | $32M | 2.2M | 14.71 | ||
| Pmv Pharmaceuticals (PMVP) | 0.5 | $31M | 501k | 61.51 | ||
| Curis Com New (CRIS) | 0.5 | $31M | NEW | 3.7M | 8.19 | |
| Berkeley Lts (BLI) | 0.5 | $29M | +8% | 325k | 89.41 | |
| Milestone Pharmaceuticals (MIST) | 0.5 | $29M | 4.3M | 6.70 | ||
| Macrogenics (MGNX) | 0.5 | $29M | 1.3M | 22.86 | ||
| Ideaya Biosciences (IDYA) | 0.4 | $26M | NEW | 1.8M | 14.00 | |
| MiMedx (MDXG) | 0.4 | $25M | 2.7M | 9.08 | ||
| Apyx Medical Corporation (APYX) | 0.4 | $24M | 3.4M | 7.20 | ||
| Fulcrum Therapeutics (FULC) | 0.4 | $24M | +80% | 2.1M | 11.71 | |
| Johnson & Johnson (JNJ) | 0.4 | $24M | 150k | 157.38 | ||
| Arbutus Biopharma (ABUS) | 0.4 | $21M | 6.0M | 3.55 | ||
| ProQR Thrapeutics N V Shs Euro (PRQR) | 0.4 | $21M | 5.0M | 4.20 | ||
| Tela Bio (TELA) | 0.3 | $21M | 1.4M | 15.04 | ||
| Penumbra (PEN) | 0.3 | $21M | NEW | 118k | 175.00 | |
| Odonate Therapeutics Ord (ODT) | 0.3 | $19M | 1.0M | 19.20 | ||
| Exagen (XGN) | 0.3 | $17M | 1.3M | 13.20 | ||
| Bellus Health Com New (BLU) | 0.3 | $16M | +23% | 5.2M | 3.04 | |
| Immunic (IMUX) | 0.2 | $14M | 921k | 15.29 | ||
| Acutus Medical (AFIB) | 0.2 | $13M | 452k | 28.81 | ||
| Regenxbio Inc equity us cm (RGNX) | 0.2 | $13M | -11% | 282k | 45.36 | |
| GenMark Diagnostics (GNMK) | 0.2 | $11M | 763k | 14.60 | ||
| Clearside Biomedical (CLSD) | 0.2 | $11M | 4.0M | 2.74 | ||
| Aptevo Therapeutics Com New (APVO) | 0.2 | $11M | NEW | 288k | 36.65 | |
| Vincera Pharma | 0.2 | $11M | NEW | 500k | 20.91 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $10M | 1.5M | 6.55 | ||
| argenx SE Sponsored Adr (ARGX) | 0.2 | $9.3M | 32k | 294.09 | ||
| La Jolla Pharmaceutical Com Par $.0001 2 (LJPC) | 0.2 | $9.3M | 2.4M | 3.88 | ||
| Helix Acquisition Corp Com Cl A | 0.1 | $8.5M | NEW | 750k | 11.37 | |
| Brainsway Sponsored Ads (BWAY) | 0.1 | $8.3M | 1.1M | 7.54 | ||
| Cerevel Therapeutics Hldng I | 0.1 | $8.3M | NEW | 500k | 16.58 | |
| Scholar Rock Hldg Corp (SRRK) | 0.1 | $8.1M | NEW | 166k | 48.53 | |
| Lifesci Acquisition Ii Corp | 0.1 | $6.9M | NEW | 650k | 10.67 | |
| Bctg Acquisition Corp (BCTG) | 0.1 | $6.9M | 600k | 11.44 | ||
| Bcls Acquisition Corp Com Cl A | 0.1 | $6.8M | NEW | 613k | 11.14 | |
| Therapeutics Acquisition Cor Com Cl A (RACA) | 0.1 | $6.8M | 490k | 13.92 | ||
| Inmode SHS (INMD) | 0.1 | $5.9M | -50% | 125k | 47.48 | |
| Arya Sciences Acquisition Com Cl A (ARYA) | 0.1 | $5.4M | 500k | 10.85 | ||
| Personalis Ord (PSNL) | 0.1 | $4.7M | -49% | 128k | 36.61 | |
| Itamar Med Sponsored Ads (ITMR) | 0.1 | $4.5M | -50% | 229k | 19.86 | |
| 5 01 Acquisition Corp Com Cl A | 0.1 | $4.0M | NEW | 392k | 10.17 | |
| Chardan Healthcare Acqu- Ord (PHGE) | 0.1 | $3.8M | 600k | 6.38 | ||
| Panacea Acquisition Corp Unit 99/99/9999 (PANA.U) | 0.1 | $3.8M | 300k | 12.76 | ||
| Immatics SHS (IMTX) | 0.1 | $3.8M | 350k | 10.79 | ||
| Chardan Healthcr Acqstn 2 Unit 99/99/9999 (CHAQ.U) | 0.1 | $3.7M | 350k | 10.59 | ||
| Twist Bioscience Corp (TWST) | 0.0 | $2.6M | 19k | 141.29 | ||
| Biodesix | 0.0 | $2.5M | NEW | 125k | 20.16 | |
| Profound Med Corp Com New (PROF) | 0.0 | $2.5M | -49% | 122k | 20.56 | |
| 908 Devices | 0.0 | $2.3M | NEW | 40k | 56.95 | |
| Maravai Lifesciences Hldgs I Com Cl A | 0.0 | $2.0M | NEW | 70k | 28.06 | |
| OraSure Technologies (OSUR) | 0.0 | $1.9M | -91% | 184k | 10.59 | |
| Aziyo Biologics Com Cl A | 0.0 | $1.7M | NEW | 125k | 13.63 | |
| Vincera Pharma *w Exp 12/24/202 | 0.0 | $1.7M | NEW | 500k | 3.30 | |
| Cerevel Therapeutics Hldng I *w Exp 06/09/202 | 0.0 | $942k | NEW | 167k | 5.65 | |
| Burning Rock Biotech Sponsored Ads (BNR) | 0.0 | $693k | 30k | 23.10 | ||
| Progenity (PROG) | 0.0 | $531k | -63% | 100k | 5.31 | |
| BiomX *w Exp 10/16/202 (PHGE.WS) | 0.0 | $480k | 600k | 0.80 | ||
| Bioatla | 0.0 | $340k | NEW | 10k | 34.00 | |
| Seer Com Cl A | 0.0 | $225k | NEW | 4.0k | 56.25 | |
Past Filings by Rtw Investments
SEC 13F filings are viewable for Rtw Investments going back to 2014
- Rtw Investments 2020 Q4 filed Feb. 16, 2021
- Rtw Investments 2020 Q3 filed Nov. 16, 2020
- Rtw Investments 2020 Q2 filed Aug. 14, 2020
- Rtw Investments 2020 Q1 filed May 15, 2020
- Rtw Investments 2019 Q4 filed Feb. 14, 2020
- Rtw Investments 2019 Q4 amended filed Feb. 14, 2020
- Rtw Investments 2019 Q3 filed Nov. 14, 2019
- Rtw Investments 2019 Q2 filed Aug. 14, 2019
- Rtw Investments 2019 Q1 filed May 15, 2019
- Rtw Investments 2018 Q4 restated filed Feb. 15, 2019
- Rtw Investments 2018 Q4 amended filed Feb. 15, 2019
- Rtw Investments 2018 Q4 filed Feb. 14, 2019
- Rtw Investments 2018 Q3 filed Nov. 14, 2018
- Rtw Investments 2018 Q2 filed Aug. 14, 2018
- Rtw Investments 2018 Q1 filed May 14, 2018
- Rtw Investments 2017 Q4 restated filed Feb. 28, 2018